Author

Petra Herzig

University of BaselORCID 0000-0001-7745-5335Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Petra Herzig1 paper · University of Basel

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell-cell communication· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Assay:flow cytometry· 1

Frequent Co-Authors

Alfred ZippeliusiD· 2 shared Didier LardinoisiD· 2 shared Heinz Philipp LaubliiD· 2 shared Anastasiya BörschiD· 1 shared Andreas ZinggiD· 1 shared Chia-wei Lin· 1 shared Emanuele Carlini· 1 shared Florian BieberichiD· 1 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Alfred ZippeliusORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintOct 4, 2023

Multimodal single-cell profiling of T cell specificity and reactivity in lung cancer

Florian Bieberich, Rodrigo Vazquez-Lombardi, Huixin Jin…·Sai T. Reddy

This study uses multimodal single-cell profiling to analyze T cell specificity and reactivity in lung cancer patients, identifying tumor- and virus-reactive T cells and their functional states.

DOI 10.1101/2023.10.04.560863

𝕏 PostBluesky

ImmunologybioRxivPreprintJun 29, 2023

Engagement of sialylated glycans with Siglec receptors on myeloid suppressor cells inhibit anti-cancer immunity via CCL2

Ronja Wieboldt, Emanuele Carlini, Chia-wei Lin…·Natalia Rodrigues Mantuano

This study shows that sialylated glycans on myeloid suppressor cells interact with Siglec receptors to suppress anti-cancer immunity through CCL2-mediated mechanisms.

DOI 10.1101/2023.06.29.547025

mouseproteomics

𝕏 PostBluesky